title: Impaired wound healing and bilateral mastectomy flap necrosis in a patient with locally advanced breast cancer after neoadjuvant Paclitaxel with bevacizumab.
authors.forename: Valentina
authors.initials: V
authors.lastname: Lazzati
authors.forename: Justyna
authors.initials: J
authors.lastname: Zygoń
authors.forename: Visnu
authors.initials: V
authors.lastname: Lohsiriwat
authors.forename: Paolo
authors.initials: P
authors.lastname: Veronesi
authors.forename: Jean Yves
authors.initials: JY
authors.lastname: Petit
mesh_terms: D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D000068258:Bevacizumab; D001943:Breast Neoplasms / Q000188:drug therapy / Q000601:surgery; D005260:Female; D006801:Humans; D008408:Mastectomy; D008875:Middle Aged; D009336:Necrosis / Q000139:chemically induced; D020360:Neoadjuvant Therapy; D017239:Paclitaxel / Q000008:administration & dosage / Q000009:adverse effects*; D011183:Postoperative Complications / Q000139:chemically induced; D012867:Skin / Q000473:pathology*; D012871:Skin Diseases / Q000139:chemically induced*; D013524:Surgical Flaps / Q000473:pathology*; D014945:Wound Healing / Q000187:drug effects*
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D017239:Paclitaxel